Skip to main content
Header logo
  • About Moberg Open link menu
    About Moberg
    • CEO Comments
    • Business Model
    • Board and Leadership
  • MOB-015
  • Sustainability
  • Investors Open link menu
    Investors
    • Results and Presentations
    • The share Open link menu
      The share
      • Major shareholders
      • Insider Trading
      • Financial Data
    • Analysts
    • Calendar
    • Corporate governance Open link menu
      Corporate governance
      • Board of directors
      • Management
      • General shareholders meetings
      • Nomination committee
      • Auditors
      • Remuneration
      • Share-based incentive program
      • Articles of Association
    • Press releases
    • Prospectus
  • Media Open link menu
    Media
    • Image Archive
    • Press Releases
  • Contact
    • EN Current language English, click to switch language
    • SV Switch to Swedish
  • Please fill out this field
Close
Please fill out this field
Press Releases
Breadcrumbs
  • Home
  • Investors
  • Press Releases

Press Releases

Press Releases Regulatory Press Releases
More
Press Releases Data
2013-11-25 08:30
Kerasal NeuroCream™ sales off to a good start -   Leading drugstore chain Walgreens intends to significantly expands distribution
Read more
2013-11-08 11:00
Moberg Pharma's nomination committee appointed
Read more
2013-11-05 08:00
Moberg Pharma AB (Publ) Interim Report January - September 2013
Read more
2013-10-25 08:30
MOBERG PHARMA SIGNS DISTRIBUTION AGREEMENT IN MIDDLE EAST AND NORTH AFRICA
Read more
2013-08-12 11:00
Moberg Pharma launches Kerasal® NeuroCream at Walmart and major U.S. drugstores
Read more
2013-08-06 08:00
Moberg Pharma interim report January - June 2013
Read more

Pagination

  • First page
  • Previous page
  • …
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Current page 60
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • …
  • Next page
  • Last page
Press Releases Data

Pagination

  • First page
  • Previous page
  • …
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • Current page 59
img

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address: 
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address: 
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Sign up

Home
Moberg Pharma´s Interim report January - September 2024

Footer

  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Cookies
  • Copyright
  • Cookie settings
  • © Moberg Pharma AB (publ) 2026